M3 (MEX:2413N) EBIT: MXN9,349 Mil (TTM As of Mar. 2026)


MEX:2413N M3 Inc MEX:2413N
86 GF Score
Price MXN183.50
GF Value MXN261.79
! 3 Warning Signs
View Full Analysis

What is M3 EBIT?

M3 MEX:2413N 86 EBIT is MXN9,349 Mil as of Mar. 2026. GuruFocus rates MEX:2413N with a GF Score™ of 86/100 and a GF Value™ of MXN261.79. The stock has 3 warning signs investors should review.

M3's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was MXN1,387 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was MXN9,349 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. M3's annualized ROC % for the quarter that ended in Mar. 2026 was 7.83%. M3's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 89.04%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. M3's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 10.71%.


M3  (MEX:2413N) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

M3's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=4839.244 * ( 1 - 26.25% )/( (46322.165 + 44856.43)/ 2 )
=3568.94245/45589.2975
=7.83 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=74412.512 - 7491.799 - ( 21278.865 - max(0, 10876.637 - 31475.185+21278.865))
=46322.165

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=72433.673 - 7914.343 - ( 21258.064 - max(0, 11364.794 - 31027.694+21258.064))
=44856.43

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

M3's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=5547.448/( ( (6192.834 + max(-241.247, 0)) + (6267.245 + max(-1121.74, 0)) )/ 2 )
=5547.448/( ( 6192.834 + 6267.245 )/ 2 )
=5547.448/6230.0395
=89.04 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(8684.287 + 0 + 1512.033) - (7491.799 + 0 + 2945.768)
=-241.247

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(8479.702 + 0 + 1289.928) - (7914.343 + 0 + 2977.027)
=-1121.74

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

M3's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=9348.834/87330.619
=10.71 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


M3 EBIT Related Terms


M3 EBIT Historical Data

* Premium members only.

The historical data trend for M3's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

M3 EBIT Chart

M3 Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16,160.03 10,031.29 7,669.11 8,990.17 8,783.01

M3 Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,710.00 2,648.25 2,087.10 3,226.63 1,386.86

MEX:2413N vs VEEV, BTSG, TEM: EBIT Comparison

For the Health Information Services subindustry, M3's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


M3 EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, M3's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where M3's EV-to-EBIT falls into.


MEX:2413N
86GF Score
M3 Inc MEX:2413N
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

M3 EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN9,349 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of MXN9,349 Mil mean?
M3 (MEX:2413N) has a EBIT of MXN9,349 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on M3.
Is M3's EBIT too high?
M3's current EBIT is MXN9,349 Mil. Overall, M3 has a GF Score™ of 86/100, reflecting its overall financial health beyond just this single metric.
How does M3's EBIT compare to VEEV and BTSG?
M3's EBIT of MXN9,349 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on M3. M3's current EBIT is MXN9,349 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is M3 stock overvalued right now?
M3 (MEX:2413N) has a current EBIT of MXN9,349 Mil. The stock's GF Value™ is MXN261.79, compared to a current price of MXN183.50 — trading 29.9% below its estimated fair value. The current EBIT is MXN9,349 Mil. M3's overall GF Score™ is 86/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For M3 (MEX:2413N), the current EBIT is MXN9,349 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is M3 (MEX:2413N) Overvalued in 2026?

Based on GuruFocus' analysis, M3 stock appears to be undervalued. The current stock price of MXN183.50 is trading 29.9% below its estimated GF Value™ of MXN261.79.

Key valuation signals for MEX:2413N:

  • EBIT: MXN9,349 Mil
  • GF Value™: MXN261.79 vs. price of MXN183.50 (29.9% below fair value)
  • GF Score™: 86/100 with 3 warning signs

No single metric tells the full story. See the MEX:2413N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


M3 Business Description

Address 1-11-44 Akasaka, Akasaka Intercity, 10th Floor, Minato-ku, Tokyo, JPN, 107-0052
M3 Inc is a Japan-based company engaged in providing medical-related services through internet-based platforms and real-world operations. The company operates six reportable segments: Medical Platform, Evidence Solutions, Career Solutions, Site Solutions, Patient Solutions, and Overseas. Its businesses include online marketing for medical professionals, clinical trial support, human resources services for medical professionals, operational support for medical institutions, and patient support services. The Overseas segment offers similar services internationally, including in the United States, the United Kingdom, China, South Korea, India, France, Germany, and Spain.
86GF Score

Get the complete analysis for MEX:2413N

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN183.50
Price
MXN261.79
GF Value